Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Tocilizumab_Abridged_HHGB-ITGC_3Apr2020
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Emerging Infections
CQ_HQ_Abridged18June2020_LPV_EU
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Emerging Infections
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.